Cargando…
Ovarian cancer progression is controlled by phenotypic changes in dendritic cells
We characterized the initiation and evolution of the immune response against a new inducible p53-dependent model of aggressive ovarian carcinoma that recapitulates the leukocyte infiltrates and cytokine milieu of advanced human tumors. Unlike other models that initiate tumors before the development...
Autores principales: | Scarlett, Uciane K., Rutkowski, Melanie R., Rauwerdink, Adam M., Fields, Jennifer, Escovar-Fadul, Ximena, Baird, Jason, Cubillos-Ruiz, Juan R., Jacobs, Ana C., Gonzalez, Jorge L., Weaver, John, Fiering, Steven, Conejo-Garcia, Jose R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302234/ https://www.ncbi.nlm.nih.gov/pubmed/22351930 http://dx.doi.org/10.1084/jem.20111413 |
Ejemplares similares
-
CD277 is a Negative Co-stimulatory Molecule Universally Expressed by Ovarian Cancer Microenvironmental Cells
por: Cubillos-Ruiz, Juan R., et al.
Publicado: (2010) -
Double Agents in the War on Cancer: Leukocytes Govern Ovarian Cancer Progression
por: Scarlett, Uciane K., et al.
Publicado: (2012) -
Constitutively activated PI3K accelerates tumor initiation and modifies histopathology of breast cancer
por: Sheen, M R, et al.
Publicado: (2016) -
Myristoylated p110α Causes Embryonic Death Due to Developmental and Vascular Defects
por: Sheen, Mee Rie, et al.
Publicado: (2015) -
Size does not matter: commensal microorganisms forge tumor-promoting inflammation and anti-tumor immunity
por: Rutkowski, Melanie R., et al.
Publicado: (2015)